Press Releases

Jun 27, 2019

Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019

Read More

Jun 26, 2019

Veracyte Announces Next-Generation Percepta Genomic Sequencing Classifier Now Available to Physicians for Improved Lung Cancer Diagnosis

Read More

Jun 24, 2019

Veracyte Named a San Francisco Bay Area “Top Workplace” For Sixth Consecutive Year

Read More

Jun 17, 2019

Veracyte Announces New Article Published in Cancer Cytopathology Detailing Clinical Utility of Its RNA Sequencing-Based Testing for Thyroid Cancer Diagnosis and Treatment

Read More

Jun 10, 2019

Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis

Read More

Jun 01, 2019

Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis

Read More

May 29, 2019

Veracyte Announces Participation in Two Upcoming Investor Conferences

Read More

May 23, 2019

Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting

Read More

May 20, 2019

Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis

Read More

May 14, 2019

Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology

Read More